Evaluation of Magnesium as an adjuvant in Ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded randomized controlled study

Objective: Different additives have been used to prolong brachial plexus block. We evaluated the effect of adding magnesium sulfate to ropivacaine for supraclavicular brachial plexus blockade. The primary endpoints were the onset and duration of sensory and motor block and duration of analgesia. Me...

Full description

Bibliographic Details
Main Authors: Kasturi Mukherjee, Anjan Das, Sandip Roy Basunia, Soumyadip Dutta, Parthajit Mandal, Anindya Mukherjee
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Journal of Research in Pharmacy Practice
Subjects:
Online Access:http://www.jrpp.net/article.asp?issn=2319-9644;year=2014;volume=3;issue=4;spage=123;epage=129;aulast=Mukherjee
id doaj-356eaf77331142cba505a593b1c11ff2
record_format Article
spelling doaj-356eaf77331142cba505a593b1c11ff22020-11-24T20:57:13ZengWolters Kluwer Medknow PublicationsJournal of Research in Pharmacy Practice2319-96442279-042X2014-01-013412312910.4103/2279-042X.145387Evaluation of Magnesium as an adjuvant in Ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded randomized controlled studyKasturi MukherjeeAnjan DasSandip Roy BasuniaSoumyadip DuttaParthajit MandalAnindya MukherjeeObjective: Different additives have been used to prolong brachial plexus block. We evaluated the effect of adding magnesium sulfate to ropivacaine for supraclavicular brachial plexus blockade. The primary endpoints were the onset and duration of sensory and motor block and duration of analgesia. Methods: One hundred patients (25-55 years) posted for elective forearm and hand surgeries under supraclavicular brachial plexus block were divided into two equal groups (Groups RM and RN) in a randomized, double-blind fashion. In group RM (n = 50), 30 ml 0.5% ropivacaine plus 150 mg (in 1 ml 0.9% saline) magnesium sulfate and in group RN (n = 50), 30 ml 0.5% ropivacaine plus 1 ml normal saline were administered in supraclavicular block. Sensory and motor block onset times and block durations, time to first analgesic use, total analgesic need, postoperative visual analog scale (VAS), hemodynamic variables, and side effects were recorded for each patient. Findings: Though with similar demographic profile and block (sensory and motor) onset time, the sensory and motor block duration and time to first analgesic use were significantly longer and the total need for rescue analgesics was lower in group RM (P = 0.026) than group RN. Postoperative VAS values at 24 h were significantly lower in group RM (P = 0.045). Intraoperative hemodynamics was comparable among two groups and no appreciable side effect was noted throughout the study period. Conclusion: It can be concluded from this study that adding magnesium sulfate to supraclavicular brachial plexus block may increase the sensory and motor block duration and time to first analgesic use, and decrease total analgesic needs, with no side effects.http://www.jrpp.net/article.asp?issn=2319-9644;year=2014;volume=3;issue=4;spage=123;epage=129;aulast=MukherjeeMagnesium sulfate; Ropivacaine; supraclavicular brachial plexus block
collection DOAJ
language English
format Article
sources DOAJ
author Kasturi Mukherjee
Anjan Das
Sandip Roy Basunia
Soumyadip Dutta
Parthajit Mandal
Anindya Mukherjee
spellingShingle Kasturi Mukherjee
Anjan Das
Sandip Roy Basunia
Soumyadip Dutta
Parthajit Mandal
Anindya Mukherjee
Evaluation of Magnesium as an adjuvant in Ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded randomized controlled study
Journal of Research in Pharmacy Practice
Magnesium sulfate; Ropivacaine; supraclavicular brachial plexus block
author_facet Kasturi Mukherjee
Anjan Das
Sandip Roy Basunia
Soumyadip Dutta
Parthajit Mandal
Anindya Mukherjee
author_sort Kasturi Mukherjee
title Evaluation of Magnesium as an adjuvant in Ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded randomized controlled study
title_short Evaluation of Magnesium as an adjuvant in Ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded randomized controlled study
title_full Evaluation of Magnesium as an adjuvant in Ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded randomized controlled study
title_fullStr Evaluation of Magnesium as an adjuvant in Ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded randomized controlled study
title_full_unstemmed Evaluation of Magnesium as an adjuvant in Ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded randomized controlled study
title_sort evaluation of magnesium as an adjuvant in ropivacaine-induced supraclavicular brachial plexus block: a prospective, double-blinded randomized controlled study
publisher Wolters Kluwer Medknow Publications
series Journal of Research in Pharmacy Practice
issn 2319-9644
2279-042X
publishDate 2014-01-01
description Objective: Different additives have been used to prolong brachial plexus block. We evaluated the effect of adding magnesium sulfate to ropivacaine for supraclavicular brachial plexus blockade. The primary endpoints were the onset and duration of sensory and motor block and duration of analgesia. Methods: One hundred patients (25-55 years) posted for elective forearm and hand surgeries under supraclavicular brachial plexus block were divided into two equal groups (Groups RM and RN) in a randomized, double-blind fashion. In group RM (n = 50), 30 ml 0.5% ropivacaine plus 150 mg (in 1 ml 0.9% saline) magnesium sulfate and in group RN (n = 50), 30 ml 0.5% ropivacaine plus 1 ml normal saline were administered in supraclavicular block. Sensory and motor block onset times and block durations, time to first analgesic use, total analgesic need, postoperative visual analog scale (VAS), hemodynamic variables, and side effects were recorded for each patient. Findings: Though with similar demographic profile and block (sensory and motor) onset time, the sensory and motor block duration and time to first analgesic use were significantly longer and the total need for rescue analgesics was lower in group RM (P = 0.026) than group RN. Postoperative VAS values at 24 h were significantly lower in group RM (P = 0.045). Intraoperative hemodynamics was comparable among two groups and no appreciable side effect was noted throughout the study period. Conclusion: It can be concluded from this study that adding magnesium sulfate to supraclavicular brachial plexus block may increase the sensory and motor block duration and time to first analgesic use, and decrease total analgesic needs, with no side effects.
topic Magnesium sulfate; Ropivacaine; supraclavicular brachial plexus block
url http://www.jrpp.net/article.asp?issn=2319-9644;year=2014;volume=3;issue=4;spage=123;epage=129;aulast=Mukherjee
work_keys_str_mv AT kasturimukherjee evaluationofmagnesiumasanadjuvantinropivacaineinducedsupraclavicularbrachialplexusblockaprospectivedoubleblindedrandomizedcontrolledstudy
AT anjandas evaluationofmagnesiumasanadjuvantinropivacaineinducedsupraclavicularbrachialplexusblockaprospectivedoubleblindedrandomizedcontrolledstudy
AT sandiproybasunia evaluationofmagnesiumasanadjuvantinropivacaineinducedsupraclavicularbrachialplexusblockaprospectivedoubleblindedrandomizedcontrolledstudy
AT soumyadipdutta evaluationofmagnesiumasanadjuvantinropivacaineinducedsupraclavicularbrachialplexusblockaprospectivedoubleblindedrandomizedcontrolledstudy
AT parthajitmandal evaluationofmagnesiumasanadjuvantinropivacaineinducedsupraclavicularbrachialplexusblockaprospectivedoubleblindedrandomizedcontrolledstudy
AT anindyamukherjee evaluationofmagnesiumasanadjuvantinropivacaineinducedsupraclavicularbrachialplexusblockaprospectivedoubleblindedrandomizedcontrolledstudy
_version_ 1716788478502502400